Archive360 Selected by Leading Fortune 500 Pharmaceutical Company to Overcome Challenges of Email Migration and Simplify eDiscovery with Archive2Azure

Global Pharma Giant, Formerly Committed to AWS as Its Cloud Platform, Turns to Archive2Azure and FastCollect for Archives to Move Nearly 100 TBs of Data into the Microsoft Cloud

NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Archive360®, the world’s leader in intelligent information management solutions, today announced that one of the world’s most respected and well-known NYSE-listed pharmaceutical companies has chosen its Archive2Azure™ as the company’s first-ever investment in Azure. Formerly 100% committed to AWS for cloud-based data management, the leading global pharma company will now use the proven solution Archive2Azure to help migrate and manage data in preparation for eDiscovery.

Initially, with a goal of preparing its data to meet eDiscovery requirements, the company had first considered other vendors but chose Archive360 instead due to technical issues with a leading migration vendor solution. The pharma organization—which had reached end-of-life with its EMC Centera system attempted to use the migration vendor’s solution, but was disappointed when corrupted indices resulted. To rescue the failing email migration - which had been blocking a key aspect of the company’s move to Office365 - Archive360 partnered with Microsoft to introduce Archive2Azure and FastCollect™ for Archives solutions into the company. The result was that Archive360 and Microsoft worked together to liberate 97 TBs of data from EV and onboard it to Azure.

“The co-sell collaboration is a win-win for Archive360 and Microsoft—particularly because in this case, the pharma client had previously been 100% committed to AWS to serve as its cloud platform,” said Bill Tolson, Vice President of Marketing, Archive360. “Once seeing the power of Archive2Azure firsthand, however, the move proved to be a gamechanger for the organization in more ways than one. It enabled them to efficiently capture, extend, onboard, and manage both structured and unstructured data into their Microsoft Cloud, lowering costs while better protecting their applications and data throughout their enterprise.”

The company now relies on Archive2Azure to ensure not only eDiscovery readiness and regulations compliance, but also simplified information management and archiving. With the transition to Archive2Azure, the company is poised to begin enjoying a dramatic decrease in the amount of time needed to manage and protect its data, as well as a drop in associated costs.

Tweet this: .@Archive360 Chosen by Leading F500 Pharma Company to Transition to Simplified eDiscovery in the Microsoft Cloud with Archive2Azure #Azure #archive #Microsoft cloud #compliance #eDiscovery

About Archive360
Archive360 is the world’s leader in intelligent information management for the Microsoft Cloud.  Its proven platform enables organizations of any size to drive down the cost, risk and uncertainty of digital transformation to and in the cloud. Archive360 is a trusted partner for onboarding, validating, and managing all enterprise digital assets, while delivering predictability, defensibility and data insights. Archive360 provides non-proprietary information management that ensures security-focused infrastructure independence. Archive360 is a global organization with a worldwide network of partners. The Archive2Azure Platform is Microsoft Azure Certified. To learn more, please visit:

Copyright ©2018. Archive360 is a registered trademark and Archive2Azure™ and FastCollect™ are trademarks of Archive360, Inc.

PR Contact:
Sabrina Sanchez
The Ventana Group, for Archive360
(925) 785-3014